基础医学与临床 ›› 2019, Vol. 39 ›› Issue (3): 321-325.

• 研究论文 • 上一篇    下一篇

腺苷A1受体激动剂减轻糖尿病并发抑郁症大鼠的认知功能障碍

杨蕙1,柳卓2,孟盼2,杜青2,王宇红2,刘检1,杨琴1   

  1. 1. 湖南中医药大学第一附属医院
    2. 湖南中医药大学
  • 收稿日期:2018-02-13 修回日期:2018-06-26 出版日期:2019-03-05 发布日期:2019-03-05
  • 通讯作者: 王宇红 E-mail:wyh107@126.com
  • 基金资助:
    基于Ca2+/D-ser/NR通路研究糖尿病并发抑郁症海马星形胶质细胞与神 经元通讯障碍机制及中药干预

Adenosine A1 receptor agonist alleviates the cognitive dysfunction in rats with diabetes mellitus and depression

  • Received:2018-02-13 Revised:2018-06-26 Online:2019-03-05 Published:2019-03-05

摘要: 目的 观察腺苷A1受体(A1R)激动剂对糖尿病并发抑郁症大鼠学习记忆功能的影响。方法 将大鼠分为对照组、模型组、二甲双胍(Met)组(Met组:灌胃给予二甲双胍0.18 g/kg 28 d)和二甲双胍联合腺苷A1受体激动剂(Met+CPA)干预组(Met+CPA组:灌胃给予二甲双胍28 d,于第22天开始腹腔注射CPA为1 mg/kg,注射给药7 d)。观察大鼠血糖水平和学习记忆功能;ELISA检测大鼠海马谷氨酸的含量;用免疫组化法和Western-blot检测海马谷氨酸转运体GLT-1和脑源性神经营养因子(BDNF)的表达。结果 与正常组比较,模型组大鼠血糖含量显著升高(P<0.01);学习和记忆功能明显下降(P<0.01);海马中谷氨酸含量明显升高(P<0.01);而GLT-1和BDNF表达显著下降(P<0.01或P<0.05)。与模型组比较,Met组大鼠仅血糖含量显著下降(P<0.01),其余指标均未见显著变化;而Met+CPA组大鼠血糖含量显著下降(P<0.01);认知功能得到明显的改善(P<0.01);海马中谷氨酸含量显著减少(P<0.01);且GLT-1和BDNF表达显著增加(P<0.01或P<0.05)。结论 激活腺苷A1受体可有效改善糖尿病并发抑郁症大鼠的认知功能,这可能与其通过减少谷氨酸释放和增加神经营养作用双途径共同减轻神经元兴奋性毒性有关。

关键词: 糖尿病并发抑郁症, 腺苷A1受体, 谷氨酸转运体1, 脑源性神经营养因子

Abstract: Objective To investigate the effect of adenosine A1 receptor (A1R) agonist on learning and memory function of diabetic rats with depression. Methods The rats were divided into control group, model group and metformin(Met)group (0.18g/kg Metformin was given by ig. for 28 days) and metformin combined with adenosine A1 receptor agonist (Met+CPA) intervention group (metformin was given by ig, and then the CPA was intraperitoneally injected at 1 mg/kg from day 22 and administered for 7 days). The levels of blood glucose and learning/memory function in rats were observed. Then the concentration of glutamate in hippocampus was detected by ELISA. At last, the expression of GLT-1 and BDNF in hippocampus were detected by immunohistochemistry and Western-blot. Results Compared with the normal group, the content of blood glucose and the learning and memory function of the model group were significantly decreased(P<0.01). In addition, the concentration of glutamate in hippocampus was significantly increased(P<0.01), while the expression of GLT-1 and BDNF were significantly decreased(P<0.01或P<0.05). Compared with the model group, only the blood glucose level decreased significantly in Met group (P<0.01) with the other indexes did not change significantly. However, there was found that the levels of glucose in blood and glutamate in hippocampus were decreased significantly in Met + CPA group(P<0.01). Furthermore, the cognitive function was significantly improved and the expression of GLT-1 and BDNF were increased(P<0.01或P<0.05). Conclusion Activation of adenosine A1 receptor can effectively improve the cognitive function of diabetic rats with depression, which may be related to its anti-neurotoxicity by reducing the glutamate release and increasing neuronal nutrition function.

Key words: diabetes mellitus with depression, adenosine A1receptor, glial glutamate transporter-1, brain derived neurotrophic factor